Exchange: NASDAQ·Updated 08:09 AM EDT
ACHV logo

ACHVAchieve Life Sciences Inc.

$5.61
$0.09
(1.58%)
Pre-Market
Prev Close $5.70
EarningsAug 6
Mkt Cap$585.16M
Vol2,396.00

About

Achieve Life Sciences, Inc. is a late-stage specialty pharmaceutical company focused on the global development and commercialization of cytisinicline as a treatment of nicotine dependence. Its products include cytisine, a plant-based alkaloid with a binding affinity to the nicotinic acetylcholine receptor. The company was founded in October 1991 and is headquartered in Bothell, WA.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
28

Frequently Asked Questions

What is Market Cap of Achieve Life Sciences Inc.?
What is the 52-week high for Achieve Life Sciences Inc.?
What is the 52-week low for Achieve Life Sciences Inc.?
What is Achieve Life Sciences Inc. stock price today?
What was Achieve Life Sciences Inc. stock price yesterday?
What is the PE ratio of Achieve Life Sciences Inc.?
What is the Price-to-Book ratio of Achieve Life Sciences Inc.?
What is the 50-day moving average of Achieve Life Sciences Inc.?
How many employees does Achieve Life Sciences Inc. have?

Advertisement|Remove ads.